» Articles » PMID: 39235726

Right Ventricular-pulmonary Artery Coupling in Patients Undergoing Cardiac Resynchronization Therapy

Overview
Publisher Springer
Specialty Radiology
Date 2024 Sep 5
PMID 39235726
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The ratio between tricuspid annular plane systolic excursion (TAPSE) and estimated pulmonary artery systolic pressure (PASP) has been shown to be a reliable, non-invasive surrogate of the right ventricular-pulmonary artery (RV-PA) coupling. The present study analysed the association between TAPSE/PASP and response to cardiac resynchronization therapy (CRT) and the prognostic role of RV-PA in patients undergoing CRT implantation. The primary endpoints were: the association between baseline TAPSE/PASP and CRT response/cardiovascular and all-cause death.

Methods And Results: All patients having undergone CRT implantation in our Center from 2016 to 2020 were included in our retrospective analysis. The RV-PA coupling was assessed by echocardiography at baseline and 1 year follow up in CRT recipients. The cut-off value of TAPSE/PASP resulted from ROC curve analysis (i.e.<0.33 mm/mmHg). A total of 229 patients (age 69.9 ± 10.1 years; 77.7% men) were included. During a mean follow-up of 44.2 ± 17.9 months, 40 (17.5%) patients died. The baseline value of TAPSE/PASP was not significantly associated with CRT response. Patients with a more impaired TAPSE/PASP ratio had significantly worse survival rates. On multivariate Cox regression, only TAPSE/PASP ratio and estimated glomerular filtration rate were independently associated with all-cause death. Finally, the TAPSE/PASP ratio significantly increased after CRT implantation in the group of "responders" whereas it did not change in 'non-responders'.

Conclusions: The baseline value of TAPSE/PASP ratio was not associated with CRT response. However, the TAPSE/PASP ratio was a strong predictor of both all-cause and cardiovascular death in CRT recipients.

References
1.
Setoguchi S, Stevenson L, Schneeweiss S . Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J. 2007; 154(2):260-6. DOI: 10.1016/j.ahj.2007.01.041. View

2.
Ponikowski P, Voors A, Anker S, Bueno H, Cleland J, Coats A . 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special.... Eur Heart J. 2016; 37(27):2129-2200. DOI: 10.1093/eurheartj/ehw128. View

3.
Glikson M, Nielsen J, Kronborg M, Michowitz Y, Auricchio A, Barbash I . 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021; 42(35):3427-3520. DOI: 10.1093/eurheartj/ehab364. View

4.
Moss A, Hall W, Cannom D, Klein H, Brown M, Daubert J . Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009; 361(14):1329-38. DOI: 10.1056/NEJMoa0906431. View

5.
Mugnai G, Donazzan L, Tomasi L, Piccoli A, Cavedon S, Manfrin M . Electrocardiographic predictors of echocardiographic response in cardiac resynchronization therapy: Update of an old story. J Electrocardiol. 2022; 75:36-43. DOI: 10.1016/j.jelectrocard.2022.10.001. View